BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
企業コードBGLC
会社名BioNexus Gene Lab Corp
上場日Mar 11, 2020
最高経営責任者「CEO」Tan (Lee Su-Leng)
従業員数30
証券種類Ordinary Share
決算期末Mar 11
本社所在地10-2 Tower B, Vertical Business Suite
都市KUALA LUMPUR
証券取引所NASDAQ OMX - NASDAQ BASIC
国Malaysia
郵便番号59200
電話番号13072416898
ウェブサイトhttps://www.bionexusgenelab.com/
企業コードBGLC
上場日Mar 11, 2020
最高経営責任者「CEO」Tan (Lee Su-Leng)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし